References

1. Shakil AO, Conry-Cantilena C, Alter HJ, Hayashi P, Kleiner DE, Tedeschi V, et al. Volunteer blood donors with anitbody to hepatitis C virus: Clinical, biochemical, virologic, and histologic features. The hepatitis C Study Group. Ann Intern Med. 1995;123(5):.

2. Seeff LB, Buskell-Bales, Wright EC, Durako SJ, Alter HJ, Hollinger FB, et al. Long-term mortality after transfusion-associated non-A, non-B Hepatitis. The National Heart, Lung, and Blood Institute Study Group. New Engl J Med. 1992;327(27):.

3. Fattovich G, Giustina G, Degos F, Tremolada F, Diodati G, Almasio P, et al. Morbidity and mortality in compensated cirrhosis type C: A retrospective follow-up study of 384 patients. Gastroenterol. 1997;112(2):.

4. Di Bisceglie AM, Goodman ZD, Ishak KG, Hoofnagle JH, Melpolder JJ, Alter HJ. Long-term clinical and histopathological follow-up of chronic posttransfusion hepatitis. Hepatology. 1991;14(6):.

5. Kiyosawa K, Sodeyama T, Tanaka E, Gibo Y, Yoshizawa K, Nakano Y, et al. Interrelationship of blood transfusion, non-A, non-B hepatitis and hepatocellular carcinoma: Analysis by detection of antibody to hepatitis C virus. Hepatology. 1990;12(4.1):.

6. Cohen M, Gish R. The Hepatitis C Help Book. New York, NY: St, Martin's Press, 2000, p. 68.

7. CDC, unpublished data.

8. MMWR 47(RR19);1-22 10/16/1998.

9. MMWR 47(RR19);23-39 10/16/1998.

10. Reichard O, Norkrans G, Fryden A, Braconier JH, Sonnerberg A, Weiland O. Randomised, double-blind, placebo-controlled trial of interferon alpha-2b with and without ribavirin for chronic hepatitis C. The Swedish Study Group. Lancet. 1998;351(9096):83-87.

11. Sostegni R, Ghisetti V, Pittaluga F, Marchiaro G, Rocca G, Borghesio E, et al. Sequential verus concomitant administration of ribavirin and interferon alfa-n3 in patients with chronic hepatitis C not responding to interferon alone: Results of a randomized, controlled trial. Hepatology. 1998;28(2):.

12. Schalm SW, Hansen BE, Chemello L, Bellobuono A, Brouwer JT, Weiland O, et al. Ribavirin enhances the efficacy but not the adverse effects of interferon in chronic hepatitis C. Meta-analysis of individual patient data from European centers. J Hepatol. 1997;26(5):.

13. Schvarcz R, Yun ZB, Seonnerborg A, Weiland O. Combined treatment with interferon alpha-2b and ribavirin for chronic hepatitis C in patients with a previous non-response or non-sustained response to interferon alone. J Med Virol. 1995;46(l):43-47.

14. Chen Z, et al. Clinical analysis of chronic hepatitis B treated with TCM compositions Fugan No. 33 by two lots. [Abstract p.2] International Symposium on Viral hepatitis and AIDS, Beijing, China, 1991. Sponsors: Beijing Association of Integration of Traditional and Western Medicine and China Medical Association.

15. Wang C, He J, Zhu C. Research of repair of liver pathologic damage in 63 cases of hepatitis with severe cholestatis by blood-cooling and circulation-invigorating Chinese herbs. [Abstract p.5] International Symposium on Viral hepatitis and AIDS, Beijing China, 1991. Sponsors: Beijing Association of Integration of Traditional and Western Medicine and China Medical Association.

16. Zhao R, Shen H. Antifibrogenesis with traditional Chinese herbs. (Abstract p.20] International Symposium on Viral hepatitis and AIDS, Beijing, China, 1991. Sponsors: Beijing Association of Integration of Traditional and Western Medicine and China Medical Association.

17. Batey RG, Bensoussen A, Hossain MA, Bollipo S. On-line Report, Gasteroenterology Unit and Cathay Herbal Labs, Sydney Australia, 1998.

18. Deng D. 30 cases of hepatitis C treated with Song Zhi Mixture. Hunan J Trad Chinese Med. 1997;13(6):27-28.

19. Yao Z, Liu Mi, Wang C. A preliminary report on the effect of 911 granules on chronic viral hepatitis of the B and C types. J Integrated Trad Western Med. 1995;3.

20. Li H, et al. Qingtui Fang applied in treating 128 cases of chronic hepatitis-C. Chinese J Integrated Trad Western Med for Liver Diseases. 1994;4(2):40.

21. Wu C, et al. 33 patients with hepatitis C treated by TCM syndrome differentiation. Chinese J Integrated Trad Western Med for Liver Diseases. 1994;4(l):44-45.

22. Gish R. California Pacific Medical Center, Liver Transplant Specialist, personal communication, 1996.

23. 12th International AIDS Conference Geneva, abstract book, June 1998.

close window